Eli Lilly

• Slimming drug concept stocks fell as Roche announced positive phase 1 results for its GLP-1/GIP new drug

  Viking Therapeutics fell 3.22%, Eli Lilly fell 1.4%, Amgen fell 1.34%, and Novo Nordisk fell 1.25%.

  US Stocks Focus May 16, 2024